MARKET INTRODUCTION

HER2 is a tyrosine kinase receptor which belongs to the ErbB/HER family. Additionally, the molecule includes ErbB3/HER3, epidermal growth factor receptor, and ErbB4/HER4. These receptors are extensively used for the treatment of cancer.

MARKET DYNAMICS

The HER2 Antibody Market growth is prominently attributed to increasing prevalence of breast cancer and extensively growing research and development activities. Additionally, increasing number of startup companies and technology collaborations are also projected to drive the market growth. However, higher treatment cost is anticipated to hamper the growth of the market during the forecast period.

MARKET SCOPE

The "HER2 Antibody Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of HER2 Antibody Market with detailed market segmentation by application and distribution channel. The HER2 Antibody Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in HER2 Antibody Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The HER2 Antibody Market is segmented on the basis of type and distribution channel. Based on type, the market is segmented as Trastuzumab, Lapatinib, Ado-trastuzumab emtansine, Pertuzumab, and Everolimus. On the basis of distribution channel, the market is categorized as hospital pharmacy, online pharmacy, retail pharmacy, and other distribution channels.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the HER2 Antibody Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The HER2 Antibody Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting HER2 Antibody Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the HER2 Antibody Market in these regions.

HER2 Antibody Market Report Analysis

HER2 Antibody Market

• 
  CAGR (2023 - 2031)

  XX%
• Market Size 2023
  US$ XX Million
• Market Size 2031
  US$ XX Million

Report Coverage

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis

• Industry landscape and competition analysis & recent developments
• Detailed company profiles

• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

• Novartis AG
• Genentech Inc.
• Abnova Corporation
• Pfizer, Inc.
• InvivoGen
• Biocon Limited
• Bio-Techne
• Celltrion, Inc.

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

By Type

• Trastuzumab
• Lapatinib
• Ado-trastuzumab emtansine
• Pertuzumab
• Everolimus

By Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
• Other Distribution Channels

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

MARKET PLAYERS

The report covers key developments in the HER2 Antibody Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from HER2 Antibody Market are anticipated to have lucrative growth opportunities in the future with the rising demand for radiotherapy devices in the global market. Below mentioned is the list of few companies engaged in the HER2 Antibody Market.

The report also includes the profiles of key players in HER2 Antibody Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

•  Novartis AG
  
•  Genentech Inc.
  
•  Abnova Corporation
  
•  Pfizer, Inc.
  
•  InvivoGen
  
•  Biocon Limited
  
•  Bio-Techne
  
•  Celltrion, Inc.
  
  

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

HER2 Antibody Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.